Heide Ford
Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homeodomain Proteins | 28 | 2023 | 490 | 7.970 |
Why?
| Protein Tyrosine Phosphatases | 14 | 2021 | 138 | 4.070 |
Why?
| Breast Neoplasms | 19 | 2020 | 1970 | 3.190 |
Why?
| Gene Expression Regulation, Neoplastic | 20 | 2023 | 1200 | 2.660 |
Why?
| Epithelial-Mesenchymal Transition | 9 | 2020 | 184 | 2.540 |
Why?
| Nuclear Proteins | 11 | 2021 | 612 | 2.120 |
Why?
| Intracellular Signaling Peptides and Proteins | 11 | 2021 | 402 | 2.070 |
Why?
| Neoplasm Metastasis | 13 | 2020 | 591 | 1.820 |
Why?
| Vascular Endothelial Growth Factor C | 3 | 2020 | 16 | 1.760 |
Why?
| Neoplastic Stem Cells | 7 | 2021 | 341 | 1.670 |
Why?
| Transforming Growth Factor beta | 5 | 2012 | 467 | 1.630 |
Why?
| Neoplasms | 13 | 2020 | 2241 | 1.590 |
Why?
| Cell Line, Tumor | 26 | 2023 | 2913 | 1.490 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 5 | 2017 | 61 | 1.470 |
Why?
| Cell Transformation, Neoplastic | 5 | 2015 | 330 | 1.430 |
Why?
| Sarcoma, Ewing | 2 | 2023 | 71 | 1.300 |
Why?
| Muscle Development | 2 | 2022 | 108 | 1.290 |
Why?
| MicroRNAs | 4 | 2015 | 652 | 1.250 |
Why?
| Drug Resistance, Neoplasm | 8 | 2017 | 693 | 1.220 |
Why?
| DNA-Binding Proteins | 5 | 2018 | 1392 | 1.200 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2019 | 162 | 1.140 |
Why?
| Zebrafish Proteins | 2 | 2022 | 283 | 1.080 |
Why?
| Transcription Factors | 7 | 2022 | 1629 | 1.060 |
Why?
| Mammary Glands, Human | 4 | 2010 | 64 | 1.060 |
Why?
| Up-Regulation | 7 | 2018 | 882 | 0.950 |
Why?
| Rhabdomyosarcoma | 1 | 2022 | 61 | 0.810 |
Why?
| Neuropilin-2 | 1 | 2020 | 3 | 0.810 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 37 | 0.800 |
Why?
| Mammary Neoplasms, Experimental | 5 | 2012 | 65 | 0.790 |
Why?
| Cell Transdifferentiation | 2 | 2010 | 32 | 0.760 |
Why?
| Oncogene Proteins, Fusion | 3 | 2023 | 205 | 0.760 |
Why?
| Animals | 39 | 2022 | 34134 | 0.740 |
Why?
| Cadherins | 2 | 2014 | 189 | 0.740 |
Why?
| Mice, SCID | 8 | 2019 | 342 | 0.720 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 80 | 0.690 |
Why?
| Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 18 | 0.680 |
Why?
| RNA-Binding Protein EWS | 2 | 2023 | 16 | 0.680 |
Why?
| Signal Transduction | 12 | 2020 | 4810 | 0.670 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 64 | 0.670 |
Why?
| Epithelial Cells | 5 | 2012 | 986 | 0.660 |
Why?
| Neoplasm Proteins | 3 | 2018 | 414 | 0.660 |
Why?
| Protein Phosphatase 2 | 1 | 2018 | 36 | 0.660 |
Why?
| Mice | 24 | 2022 | 15621 | 0.650 |
Why?
| Transcriptional Activation | 2 | 2018 | 367 | 0.640 |
Why?
| Zinc Finger Protein GLI1 | 1 | 2017 | 21 | 0.630 |
Why?
| Mice, Inbred NOD | 6 | 2019 | 571 | 0.620 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 124 | 0.610 |
Why?
| Anion Transport Proteins | 1 | 2017 | 12 | 0.610 |
Why?
| Paracrine Communication | 1 | 2017 | 60 | 0.600 |
Why?
| B7-H1 Antigen | 1 | 2018 | 144 | 0.590 |
Why?
| Genetic Heterogeneity | 1 | 2016 | 58 | 0.580 |
Why?
| Cell Proliferation | 11 | 2020 | 2363 | 0.570 |
Why?
| Down-Regulation | 2 | 2015 | 639 | 0.570 |
Why?
| Ribosomal Proteins | 1 | 2015 | 70 | 0.550 |
Why?
| Twist-Related Protein 1 | 1 | 2015 | 10 | 0.540 |
Why?
| Cell Cycle | 4 | 2013 | 577 | 0.530 |
Why?
| Mammary Glands, Animal | 3 | 2010 | 139 | 0.520 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2016 | 495 | 0.520 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 554 | 0.520 |
Why?
| Humans | 53 | 2023 | 121869 | 0.510 |
Why?
| Mesoderm | 3 | 2009 | 146 | 0.510 |
Why?
| Epithelium | 3 | 2009 | 303 | 0.500 |
Why?
| Neoplasm Transplantation | 6 | 2014 | 248 | 0.490 |
Why?
| Branchio-Oto-Renal Syndrome | 2 | 2013 | 5 | 0.480 |
Why?
| Neoplasm Recurrence, Local | 1 | 2019 | 884 | 0.470 |
Why?
| Transcription, Genetic | 3 | 2014 | 1403 | 0.460 |
Why?
| Molecular Targeted Therapy | 2 | 2015 | 373 | 0.450 |
Why?
| Lung Neoplasms | 3 | 2019 | 2237 | 0.450 |
Why?
| Superoxide Dismutase | 1 | 2014 | 347 | 0.440 |
Why?
| Lymphangiogenesis | 1 | 2012 | 22 | 0.440 |
Why?
| Female | 26 | 2021 | 63903 | 0.430 |
Why?
| Genes, Tumor Suppressor | 1 | 2012 | 82 | 0.430 |
Why?
| Cell Differentiation | 7 | 2022 | 1775 | 0.430 |
Why?
| Gene Expression Regulation, Developmental | 5 | 2017 | 862 | 0.430 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 169 | 0.420 |
Why?
| Protein Binding | 7 | 2020 | 2017 | 0.420 |
Why?
| Antineoplastic Agents | 3 | 2020 | 2017 | 0.400 |
Why?
| Mice, Nude | 7 | 2017 | 682 | 0.400 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 53 | 0.390 |
Why?
| Genes, Homeobox | 3 | 2022 | 49 | 0.380 |
Why?
| Bone Neoplasms | 1 | 2012 | 207 | 0.370 |
Why?
| Cyclin A | 3 | 2009 | 15 | 0.360 |
Why?
| Embryonic Development | 1 | 2010 | 130 | 0.350 |
Why?
| Mice, Inbred BALB C | 4 | 2019 | 1237 | 0.350 |
Why?
| Genomic Instability | 1 | 2008 | 40 | 0.330 |
Why?
| Cell Movement | 5 | 2020 | 909 | 0.320 |
Why?
| Gene Regulatory Networks | 2 | 2023 | 255 | 0.310 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1438 | 0.300 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2020 | 769 | 0.300 |
Why?
| Ovarian Neoplasms | 2 | 2012 | 415 | 0.290 |
Why?
| Heterografts | 3 | 2017 | 135 | 0.280 |
Why?
| Prognosis | 5 | 2019 | 3603 | 0.280 |
Why?
| Retina | 1 | 2008 | 270 | 0.270 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 317 | 0.270 |
Why?
| Gene Amplification | 1 | 2005 | 101 | 0.260 |
Why?
| Zebrafish | 2 | 2022 | 469 | 0.250 |
Why?
| Protein Stability | 2 | 2018 | 160 | 0.240 |
Why?
| Integrins | 1 | 2023 | 86 | 0.230 |
Why?
| Myogenin | 1 | 2022 | 16 | 0.220 |
Why?
| MyoD Protein | 1 | 2022 | 32 | 0.220 |
Why?
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 19 | 0.220 |
Why?
| MCF-7 Cells | 2 | 2020 | 119 | 0.210 |
Why?
| Models, Biological | 4 | 2017 | 1772 | 0.210 |
Why?
| Disease Progression | 3 | 2015 | 2582 | 0.210 |
Why?
| Cell Survival | 2 | 2017 | 1092 | 0.200 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 466 | 0.200 |
Why?
| Transplantation, Heterologous | 3 | 2012 | 199 | 0.200 |
Why?
| Small Molecule Libraries | 2 | 2019 | 83 | 0.200 |
Why?
| Cell Dedifferentiation | 2 | 2010 | 30 | 0.190 |
Why?
| BRCA1 Protein | 1 | 2020 | 58 | 0.190 |
Why?
| Enzyme Inhibitors | 4 | 2021 | 841 | 0.180 |
Why?
| Apoptosis | 3 | 2019 | 2564 | 0.180 |
Why?
| Hedgehog Proteins | 1 | 2020 | 176 | 0.180 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 11 | 0.180 |
Why?
| Glioblastoma | 1 | 2021 | 262 | 0.170 |
Why?
| Cyclin A1 | 3 | 2009 | 4 | 0.170 |
Why?
| Antigens, CD | 2 | 2014 | 468 | 0.170 |
Why?
| Gene Expression Profiling | 3 | 2012 | 1649 | 0.170 |
Why?
| Mutation | 1 | 2009 | 3520 | 0.170 |
Why?
| Tumor Cells, Cultured | 2 | 2019 | 907 | 0.160 |
Why?
| HEK293 Cells | 2 | 2018 | 655 | 0.160 |
Why?
| Cell Growth Processes | 2 | 2008 | 55 | 0.160 |
Why?
| Veratrum Alkaloids | 1 | 2017 | 18 | 0.160 |
Why?
| RNA, Small Interfering | 2 | 2017 | 576 | 0.160 |
Why?
| Maxilla | 1 | 2017 | 33 | 0.160 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 901 | 0.160 |
Why?
| Proteolysis | 2 | 2017 | 142 | 0.150 |
Why?
| Basigin | 1 | 2017 | 26 | 0.150 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 448 | 0.140 |
Why?
| Promoter Regions, Genetic | 3 | 2010 | 1211 | 0.140 |
Why?
| Clone Cells | 1 | 2016 | 248 | 0.140 |
Why?
| Cellular Reprogramming | 1 | 2017 | 88 | 0.140 |
Why?
| Protein Structure, Tertiary | 2 | 2009 | 833 | 0.140 |
Why?
| Membrane Transport Proteins | 1 | 2017 | 135 | 0.140 |
Why?
| Multigene Family | 2 | 2008 | 200 | 0.140 |
Why?
| Immunohistochemistry | 2 | 2018 | 1738 | 0.140 |
Why?
| Endothelin-1 | 1 | 2017 | 167 | 0.140 |
Why?
| Tumor Burden | 2 | 2017 | 280 | 0.140 |
Why?
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.130 |
Why?
| Trans-Activators | 2 | 2010 | 395 | 0.130 |
Why?
| Claudins | 1 | 2014 | 22 | 0.130 |
Why?
| Cell Nucleus | 2 | 2009 | 598 | 0.130 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 121 | 0.130 |
Why?
| Mass Spectrometry | 1 | 2018 | 704 | 0.130 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2015 | 84 | 0.130 |
Why?
| Genes, MHC Class I | 2 | 2005 | 34 | 0.120 |
Why?
| Survival Rate | 1 | 2019 | 1828 | 0.120 |
Why?
| Pyrimidines | 1 | 2017 | 393 | 0.120 |
Why?
| Tumor Microenvironment | 1 | 2017 | 451 | 0.120 |
Why?
| Gene Expression | 3 | 2009 | 1530 | 0.120 |
Why?
| Transfection | 3 | 2017 | 919 | 0.120 |
Why?
| Aldehyde Dehydrogenase | 1 | 2014 | 134 | 0.120 |
Why?
| Biomedical Research | 1 | 2020 | 632 | 0.120 |
Why?
| G1 Phase | 1 | 2013 | 72 | 0.120 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2013 | 37 | 0.120 |
Why?
| Gene Expression Regulation | 1 | 2023 | 2499 | 0.120 |
Why?
| Pyridines | 1 | 2017 | 462 | 0.120 |
Why?
| Phosphorylation | 1 | 2018 | 1684 | 0.120 |
Why?
| Brain Neoplasms | 1 | 2021 | 1031 | 0.120 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2018 | 707 | 0.110 |
Why?
| Autophagy | 1 | 2016 | 321 | 0.110 |
Why?
| Disease-Free Survival | 1 | 2014 | 678 | 0.110 |
Why?
| Cluster Analysis | 2 | 2012 | 512 | 0.110 |
Why?
| Antibodies, Neoplasm | 1 | 2012 | 29 | 0.110 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1075 | 0.110 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2017 | 141 | 0.110 |
Why?
| Etoposide | 1 | 2012 | 159 | 0.110 |
Why?
| Reactive Oxygen Species | 1 | 2014 | 580 | 0.110 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 800 | 0.100 |
Why?
| Repressor Proteins | 1 | 2014 | 393 | 0.100 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 183 | 0.100 |
Why?
| Amino Acid Sequence | 4 | 2014 | 2113 | 0.100 |
Why?
| Proteasome Inhibitors | 1 | 2011 | 47 | 0.100 |
Why?
| Lymphatic Metastasis | 1 | 2012 | 312 | 0.100 |
Why?
| DNA Damage | 2 | 2017 | 385 | 0.100 |
Why?
| Cell Death | 2 | 2021 | 343 | 0.100 |
Why?
| Doxorubicin | 1 | 2012 | 312 | 0.100 |
Why?
| Energy Metabolism | 1 | 2017 | 869 | 0.100 |
Why?
| Antioxidants | 1 | 2014 | 580 | 0.100 |
Why?
| Antigens, Differentiation | 1 | 2010 | 81 | 0.090 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 548 | 0.090 |
Why?
| Metaplasia | 1 | 2009 | 58 | 0.090 |
Why?
| Smad3 Protein | 1 | 2009 | 47 | 0.090 |
Why?
| Lymphoma | 1 | 2011 | 185 | 0.090 |
Why?
| Salivary Proteins and Peptides | 1 | 2009 | 10 | 0.090 |
Why?
| Pancreatic Neoplasms | 1 | 2017 | 771 | 0.090 |
Why?
| Follow-Up Studies | 1 | 2019 | 4883 | 0.090 |
Why?
| Submandibular Gland | 1 | 2009 | 17 | 0.090 |
Why?
| Mutant Proteins | 1 | 2009 | 103 | 0.090 |
Why?
| Lactation | 1 | 2010 | 179 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2009 | 286 | 0.080 |
Why?
| Protein Structure, Secondary | 1 | 2009 | 343 | 0.080 |
Why?
| Eye Neoplasms | 1 | 2008 | 14 | 0.080 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 142 | 0.080 |
Why?
| Oxidative Stress | 1 | 2014 | 1194 | 0.080 |
Why?
| Protein Transport | 1 | 2009 | 418 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 1008 | 0.080 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 1012 | 0.080 |
Why?
| Allosteric Regulation | 2 | 2019 | 88 | 0.080 |
Why?
| Structure-Activity Relationship | 2 | 2021 | 533 | 0.070 |
Why?
| Ubiquitin | 1 | 2006 | 68 | 0.070 |
Why?
| Amino Acid Motifs | 1 | 2006 | 207 | 0.070 |
Why?
| Blotting, Western | 2 | 2011 | 1226 | 0.070 |
Why?
| Crystallography, X-Ray | 2 | 2019 | 432 | 0.070 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2005 | 19 | 0.070 |
Why?
| Ovary | 1 | 2007 | 213 | 0.070 |
Why?
| Antigens, CD1 | 1 | 2005 | 57 | 0.070 |
Why?
| Chickens | 1 | 2005 | 184 | 0.070 |
Why?
| Precipitin Tests | 1 | 2004 | 97 | 0.060 |
Why?
| Models, Molecular | 3 | 2019 | 1459 | 0.060 |
Why?
| Phylogeny | 2 | 2005 | 823 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2009 | 2048 | 0.060 |
Why?
| Cell Line | 2 | 2014 | 2815 | 0.060 |
Why?
| Child | 1 | 2023 | 19282 | 0.060 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 26 | 0.060 |
Why?
| Cyclin D1 | 1 | 2003 | 63 | 0.060 |
Why?
| Dogfish | 1 | 2003 | 4 | 0.060 |
Why?
| RNA, Messenger | 2 | 2012 | 2746 | 0.060 |
Why?
| Fibroblasts | 1 | 2008 | 854 | 0.060 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 5054 | 0.060 |
Why?
| DNA, Complementary | 1 | 2003 | 274 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 2046 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2012 | 3800 | 0.050 |
Why?
| Cell Division | 1 | 2004 | 786 | 0.050 |
Why?
| DNA | 1 | 2009 | 1399 | 0.050 |
Why?
| Neovascularization, Pathologic | 1 | 2004 | 292 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2005 | 463 | 0.050 |
Why?
| Developmental Biology | 1 | 2020 | 17 | 0.050 |
Why?
| Neural Stem Cells | 1 | 2021 | 119 | 0.050 |
Why?
| Cell Plasticity | 1 | 2020 | 25 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 483 | 0.050 |
Why?
| Molecular Sequence Data | 3 | 2014 | 2948 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 2 | 2014 | 381 | 0.040 |
Why?
| Terminology as Topic | 1 | 2020 | 221 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 216 | 0.040 |
Why?
| Treatment Outcome | 1 | 2012 | 9654 | 0.040 |
Why?
| Pregnancy | 1 | 2010 | 5663 | 0.040 |
Why?
| Consensus | 1 | 2020 | 537 | 0.040 |
Why?
| Sp7 Transcription Factor | 1 | 2017 | 8 | 0.040 |
Why?
| Zygoma | 1 | 2017 | 11 | 0.040 |
Why?
| Serrate-Jagged Proteins | 1 | 2017 | 30 | 0.040 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2017 | 23 | 0.040 |
Why?
| Receptor, Endothelin A | 1 | 2017 | 60 | 0.040 |
Why?
| Branchial Region | 1 | 2017 | 41 | 0.040 |
Why?
| Autophagy-Related Proteins | 1 | 2016 | 49 | 0.040 |
Why?
| Craniofacial Abnormalities | 1 | 2017 | 67 | 0.040 |
Why?
| Diphtheria Toxin | 1 | 2016 | 76 | 0.040 |
Why?
| Receptors, Notch | 1 | 2017 | 89 | 0.040 |
Why?
| Integrases | 1 | 2017 | 117 | 0.040 |
Why?
| Body Patterning | 1 | 2017 | 142 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2017 | 236 | 0.040 |
Why?
| Epidermal Growth Factor | 1 | 2016 | 174 | 0.040 |
Why?
| Neural Crest | 1 | 2017 | 137 | 0.030 |
Why?
| DNA Repair | 1 | 2017 | 204 | 0.030 |
Why?
| Statistics, Nonparametric | 2 | 2009 | 435 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 300 | 0.030 |
Why?
| Cell Adhesion | 1 | 2017 | 454 | 0.030 |
Why?
| Calcium Signaling | 1 | 2017 | 219 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2016 | 398 | 0.030 |
Why?
| RNA Interference | 1 | 2017 | 476 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 77 | 0.030 |
Why?
| Calorimetry | 1 | 2014 | 60 | 0.030 |
Why?
| Molecular Docking Simulation | 1 | 2014 | 100 | 0.030 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 25 | 0.030 |
Why?
| Magnesium | 1 | 2014 | 155 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2016 | 662 | 0.030 |
Why?
| Amino Acids | 1 | 2017 | 458 | 0.030 |
Why?
| DNA Primers | 2 | 2005 | 546 | 0.030 |
Why?
| Phenylhydrazines | 1 | 2012 | 3 | 0.030 |
Why?
| Adult | 1 | 2015 | 32683 | 0.030 |
Why?
| Miniaturization | 1 | 2012 | 23 | 0.030 |
Why?
| Protein Phosphatase 2C | 1 | 2012 | 15 | 0.030 |
Why?
| Fluoresceins | 1 | 2012 | 46 | 0.030 |
Why?
| Enzyme Assays | 1 | 2012 | 24 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 45 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 244 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2012 | 70 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6889 | 0.030 |
Why?
| Spleen | 2 | 2005 | 515 | 0.030 |
Why?
| Spectrometry, Fluorescence | 1 | 2012 | 172 | 0.030 |
Why?
| Antibody Specificity | 1 | 2012 | 192 | 0.030 |
Why?
| DNA Fragmentation | 1 | 2011 | 50 | 0.030 |
Why?
| Sequence Analysis, DNA | 2 | 2005 | 774 | 0.030 |
Why?
| Fas Ligand Protein | 1 | 2011 | 60 | 0.030 |
Why?
| High-Throughput Screening Assays | 1 | 2012 | 122 | 0.020 |
Why?
| Mutation, Missense | 1 | 2013 | 309 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 340 | 0.020 |
Why?
| Male | 2 | 2021 | 60475 | 0.020 |
Why?
| Brain | 1 | 2021 | 2693 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1700 | 0.020 |
Why?
| Tissue Distribution | 1 | 2009 | 340 | 0.020 |
Why?
| Organ Size | 1 | 2009 | 482 | 0.020 |
Why?
| Bursa of Fabricius | 1 | 2005 | 2 | 0.020 |
Why?
| Blotting, Southern | 1 | 2005 | 73 | 0.020 |
Why?
| Sequence Homology | 1 | 2005 | 41 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 201 | 0.020 |
Why?
| Conserved Sequence | 1 | 2005 | 224 | 0.020 |
Why?
| Sequence Alignment | 1 | 2005 | 345 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2005 | 530 | 0.020 |
Why?
| Mice, Knockout | 1 | 2009 | 2727 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2003 | 572 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 286 | 0.010 |
Why?
| Base Sequence | 1 | 2005 | 2217 | 0.010 |
Why?
| Biological Evolution | 1 | 2003 | 460 | 0.010 |
Why?
| Genetic Variation | 1 | 2003 | 961 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2005 | 2107 | 0.010 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|